These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 1377143)

  • 21. Pretransplant virological markers hepatitis C virus genotype and viremia level are not helpful in predicting individual outcome after orthotopic liver transplantation.
    Berg T; Hopf U; Bechstein WO; Müller AR; Fukumoto T; Neuhaus R; Lobeck H; Neuhaus P
    Transplantation; 1998 Jul; 66(2):225-8. PubMed ID: 9701269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
    Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
    Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation.
    Sreekumar R; Gonzalez-Koch A; Maor-Kendler Y; Batts K; Moreno-Luna L; Poterucha J; Burgart L; Wiesner R; Kremers W; Rosen C; Charlton MR
    Hepatology; 2000 Nov; 32(5):1125-30. PubMed ID: 11050065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Hepatitis C Viremia on Posttransplant Diabetes Mellitus in Liver Transplant Recipients.
    Klein K; Nelson J; Long C; Speeg K; Alkhouri N; Hall R
    Prog Transplant; 2022 Mar; 32(1):73-77. PubMed ID: 34874192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue quantification of hepatitis C virus RNA with morphologic correlation in the diagnosis of recurrent hepatitis C virus in human liver transplants.
    Aardema KL; Nakhleh RE; Terry LK; Burd EM; Ma CK; Moonka DK; Brown KA; Abouljoud MS
    Mod Pathol; 1999 Nov; 12(11):1043-9. PubMed ID: 10574601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post-transplant recurrent hepatitis C: immunohistochemical detection of hepatitis C virus core antigen and possible pathogenic implications.
    Pessôa MG; Alves VA; Wakamatsu A; Gomes JG; Maertens G; van der Borght B; Kim M; Ferrell L; Wright TL
    Liver Int; 2008 Jul; 28(6):807-13. PubMed ID: 18422936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective study of hepatitis C virus infection in renal allograft recipients.
    Roth D; Zucker K; Cirocco R; Burke G; Ciancio G; Esquenazi V; Swanson SJ; Miller J
    Transplantation; 1996 Mar; 61(6):886-9. PubMed ID: 8623154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrence of hepatitis C following orthotopic liver transplantation: a polymerase chain reaction and histological study.
    Sallie R; Cohen AT; Tibbs CJ; Portmann BC; Rayner A; O'Grady JG; Tan KC; Williams R
    J Hepatol; 1994 Oct; 21(4):536-42. PubMed ID: 7814799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between hepatitis C genotype and severity of recurrent hepatitis C after liver transplantation.
    Gordon FD; Poterucha JJ; Germer J; Zein NN; Batts KP; Gross JB; Wiesner R; Persing D
    Transplantation; 1997 May; 63(10):1419-23. PubMed ID: 9175804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term outcome of hepatitis C infection after liver transplantation.
    Gane EJ; Portmann BC; Naoumov NV; Smith HM; Underhill JA; Donaldson PT; Maertens G; Williams R
    N Engl J Med; 1996 Mar; 334(13):815-20. PubMed ID: 8596547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of hepatitis C virus infection on renal allograft recipients.
    Roth D; Zucker K; Cirocco R; DeMattos A; Burke GW; Nery J; Esquenazi V; Babischkin S; Miller J
    Kidney Int; 1994 Jan; 45(1):238-44. PubMed ID: 7510350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serologic, virologic, and histologic characteristics of chronic phase hepatitis C virus disease in children infected by transfusion.
    Matsuoka S; Tatara K; Hayabuchi Y; Taguchi Y; Mori K; Honda H; Itou S; Yuasa Y; Kuroda Y
    Pediatrics; 1994 Dec; 94(6 Pt 1):919-22. PubMed ID: 7971011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolution of hepatitis C virus in liver allografts.
    Demetris AJ
    Liver Transpl; 2009 Nov; 15 Suppl 2():S35-41. PubMed ID: 19876940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C virus genotypes and quantification of serum hepatitis C RNA in liver transplant recipients. Relationship with histologic outcome of recurrent hepatitis C.
    Costes V; Durand L; Pageaux GP; Ducos J; Mondain AM; Picot MC; Domergue J; Larrey D; Baldet P
    Am J Clin Pathol; 1999 Feb; 111(2):252-8. PubMed ID: 9930149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virological and histological features of hepatitis C virus (HCV) infection in kidney transplant recipients.
    Fabrizi F; Lunghi G; Marai P; Marcelli D; Guarnori I; Raffaele L; Erba G; Pagano A; Locatelli F
    Nephrol Dial Transplant; 1996 Jan; 11(1):159-64. PubMed ID: 8649626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal variation in hepatitis C virus (HCV) viraemia and early course of HCV infection after liver transplantation for HCV cirrhosis: the role of different immunosuppressive regimens.
    Papatheodoridis GV; Barton SG; Andrew D; Clewley G; Davies S; Dhillon AP; Dusheiko G; Davidson B; Rolles K; Burroughs AK
    Gut; 1999 Sep; 45(3):427-34. PubMed ID: 10446114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural history of hepatitis C and outcomes following liver transplantation.
    Charlton M
    Clin Liver Dis; 2003 Aug; 7(3):585-602. PubMed ID: 14509528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrosing cholestatic hepatitis in hepatitis C virus-infected renal transplant recipients.
    Muñoz De Bustillo E; Ibarrola C; Colina F; Castellano G; Fuertes A; Andrés A; Aguado JM; Rodicio JL; Morales JM
    J Am Soc Nephrol; 1998 Jun; 9(6):1109-13. PubMed ID: 9621297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reinfection of liver graft by hepatitis C virus after liver transplantation.
    Féray C; Samuel D; Thiers V; Gigou M; Pichon F; Bismuth A; Reynes M; Maisonneuve P; Bismuth H; Bréchot C
    J Clin Invest; 1992 Apr; 89(4):1361-5. PubMed ID: 1313453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Cytomegalovirus Infection on Severe Hepatitis C Recurrence in Patients Undergoing Liver Transplantation.
    Caston JJ; Castells L; Varo E; Gomez MA; de la Mata M; Campos-Varela I; Lumbreras C; Gonzalez-Dieguez L; Fabregat J; Herrero I; Salcedo M; Sanchez-Antolín G; Torre-Cisneros J
    Transplantation; 2016 Mar; 100(3):593-9. PubMed ID: 26371595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.